Total Payments
$2,165
2024 Payments
$240.19
Companies
24
Transactions
83
Medicare Patients
1,828
Medicare Billing
$133,261
Payment Breakdown by Category
Food & Beverage$2,165 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,165 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $308.68 | 13 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $236.91 | 15 | $0 (2022) |
| Esperion Therapeutics, Inc. | $171.96 | 7 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $158.79 | 8 | $0 (2023) |
| Abbott Laboratories | $157.86 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $133.06 | 9 | $0 (2022) |
| Medtronic, Inc. | $130.86 | 1 | $0 (2023) |
| Solventum Corporation | $124.27 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $117.86 | 3 | $0 (2022) |
| Organogenesis Inc. | $115.92 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.19 | 4 | Solventum Corporation ($124.27) |
| 2023 | $779.45 | 26 | ABBVIE INC. ($308.68) |
| 2022 | $522.29 | 31 | Novartis Pharmaceuticals Corporation ($133.06) |
| 2021 | $623.28 | 22 | Esperion Therapeutics, Inc. ($171.96) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Solventum Corporation | V.A.C.INSTILL (Device), V.A.C. SIMPLICITY, V.A.C.ULTA | Food and Beverage | Cash or cash equivalent | $14.45 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 06/27/2024 | Solventum Corporation | ACTIV.A.C. (Device), V.A.C. DERMATAC, PREVENA | Food and Beverage | Cash or cash equivalent | $47.32 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 06/04/2024 | Solventum Corporation | 3M Cavilon (Device), ACTIV.A.C., PROMOGRAN PRISMA | Food and Beverage | Cash or cash equivalent | $62.50 | General |
| Category: Skin Integrity | ||||||
| 03/13/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $115.92 | General |
| 11/21/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.51 | General |
| Category: Opioid Analgesic | ||||||
| 10/25/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $107.29 | General |
| Category: Obesity | ||||||
| 10/25/2023 | NeuroMetrix Inc | — | Food and Beverage | In-kind items and services | $16.78 | General |
| 10/23/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $130.86 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/06/2023 | Collegium Pharmaceutical, Inc. | BELBUCA (Drug) | Food and Beverage | Cash or cash equivalent | $63.77 | General |
| Category: Opioid Analgesic | ||||||
| 09/05/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $46.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2023 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Orthopedic | ||||||
| 08/07/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.02 | General |
| Category: Opioid Analgesic | ||||||
| 08/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.01 | General |
| Category: Opioid Analgesic | ||||||
| 07/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: NEUROSCIENCE | ||||||
| 07/05/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $9.66 | General |
| Category: Opioid Analgesic | ||||||
| 05/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.61 | General |
| Category: Opioid Analgesic | ||||||
| 03/27/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $0.19 | General |
| Category: Opioid Analgesic | ||||||
| 03/09/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 949 | 1,366 | $159,423 | $66,354 |
| 2022 | 4 | 363 | 416 | $76,844 | $28,947 |
| 2021 | 5 | 333 | 390 | $67,099 | $25,200 |
| 2020 | 4 | 183 | 227 | $40,295 | $12,760 |
Total Patients
1,828
Total Services
2,399
Medicare Billing
$133,261
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 256 | 502 | $58,232 | $26,627 | 45.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 150 | 239 | $28,680 | $13,891 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 177 | $31,329 | $12,622 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $13,038 | $4,456 | 34.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 83 | 97 | $6,984 | $3,242 | 46.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $9,342 | $3,205 | 34.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 17 | 23 | $5,423 | $998.26 | 18.4% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 12 | 16 | $3,120 | $584.70 | 18.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 164 | 165 | $2,475 | $467.60 | 18.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 16 | 26 | $520.00 | $144.92 | 27.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 13 | 14 | $280.00 | $114.59 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 296 | 346 | $70,522 | $25,904 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 29 | $3,364 | $1,651 | 49.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 23 | 23 | $2,760 | $1,340 | 48.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 18 | $198.00 | $53.46 | 27.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 253 | 303 | $62,418 | $23,716 | 38.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 19 | 20 | $2,740 | $1,055 | 38.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 24 | 24 | $1,132 | $225.12 | 19.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 12 | 14 | $490.00 | $118.44 | 24.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 25 | 29 | $319.00 | $84.64 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 134 | 172 | $37,018 | $11,894 | 32.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 13 | $1,807 | $624.99 | 34.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 15 | 16 | $1,184 | $162.68 | 13.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 21 | 26 | $286.00 | $78.00 | 27.3% |
About Robin Riddle, NP
Robin Riddle, NP is a Family healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2019. The National Provider Identifier (NPI) number assigned to this provider is 1205487568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robin Riddle, NP has received a total of $2,165 in payments from pharmaceutical and medical device companies, with $240.19 received in 2024. These payments were reported across 83 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,165).
As a Medicare-enrolled provider, Riddle has provided services to 1,828 Medicare beneficiaries, totaling 2,399 services with total Medicare billing of $133,261. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Fort Wayne, IN
- Active Since 09/26/2019
- Last Updated 10/24/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1205487568
Products in Payments
- QULIPTA (Drug) $265.95
- LifeVest (Device) $236.91
- NEXLETOL (Drug) $171.96
- CardioMEMS HF System (Device) $157.86
- INTELLIS ADAPTIVESTIM (Device) $130.86
- Wegovy (Drug) $107.29
- VERQUVO (Drug) $103.61
- XTAMPZA (Drug) $94.83
- ENTRESTO (Drug) $91.35
- FARXIGA (Drug) $78.44
- JARDIANCE (Drug) $71.67
- BELBUCA (Drug) $63.77
- 3M Cavilon (Device) $62.50
- ACTIV.A.C. (Device) $47.32
- QUTENZA (Drug) $46.00
- UBRELVY (Drug) $42.73
- XARELTO (Drug) $41.74
- LEQVIO (Drug) $41.71
- BRILINTA (Drug) $39.42
- Vascepa (Drug) $23.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Fort Wayne
Justin Brown, Np, NP
Family — Payments: $71,894
Family $71,894
Mrs. Tracy Johnson, Np, NP
Family — Payments: $21,658
Family $21,658
Benjamin Giarmo, Np, NP
Family — Payments: $16,976
Family $16,976
Mr. Grant Blauvelt, Msn, Fnp-Bc, MSN, FNP-BC
Family — Payments: $16,493
Family $16,493
Ms. Katarzyna Sedlaczek, Fnp-C, FNP-C
Family — Payments: $16,146
Family $16,146
Brandy Dantzer, Np, NP
Family — Payments: $15,826
Family $15,826